Five Prime Therapeutics to Present at BIO CEO

        Print
| Source: Five Prime Therapeutics, Inc.

SOUTH SAN FRANCISCO, Calif., Feb. 3, 2014 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that Lewis T. "Rusty" Williams, M.D., Ph.D., President and Chief Executive Officer of Five Prime, will present at the 16th Annual BIO CEO & Investor Conference on Monday, February 10, at 2 p.m. Eastern Time. The conference will take place at the Waldorf Astoria Hotel in New York City.

The live webcast will be accessible at http://investor.fiveprime.com/events.cfm or as a direct feed from http://www.veracast.com/webcasts/bio/ceoinvestor2014/69136447092.cfm. Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.

About Five Prime

Five Prime is a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases. Five Prime has developed a library of more than 5,700 human extracellular proteins. Five Prime screens this comprehensive library with its proprietary high-throughput protein screening technologies to identify new targets for protein therapeutics. Additional information can be found at the company's website: www.fiveprime.com.

COMPANY CONTACT:

Amy Kendall
Corporate Communications
415-365-5776